Literature DB >> 12700693

Altered behavioral response to dopamine D3 receptor agonists 7-OH-DPAT and PD 128907 following repetitive amphetamine administration.

Neil M Richtand1, Jeffrey A Welge, Beth Levant, Aaron D Logue, Scott Hayes, Laurel M Pritchard, Thomas D Geracioti, Lique M Coolen, S Paul Berger.   

Abstract

Behavioral sensitization, the progressive and enduring enhancement of certain behaviors following repetitive drug use, is mediated in part by dopaminergic pathways. Increased locomotor response to drug treatment, a sensitizable behavior, is modulated by an opposing balance of dopamine receptor subtypes, with D1/D2 dopamine receptor stimulation increasing and D3 dopamine receptor activation inhibiting amphetamine-induced locomotion. We hypothesize that tolerance of D3 receptor locomotor inhibition contributes to behavioral sensitization. In order to test the hypothesis that expression of behavioral sensitization results in part from release of D3 receptor-mediated inhibition, thereby resulting in decreased response to D3 receptor agonists, we examined the effect of repetitive amphetamine administration on the behavioral response to the D3 receptor preferring agonists 7-OH-DPAT and PD 128907. D3-selective effects have recently been described for both drugs at a low dose. At 1 week following completion of a repetitive treatment regimen, amphetamine-pretreated rats displayed a decreased response to D3-selective doses of both 7-OH-DPAT and PD 128907, when compared to animals receiving saline pretreatment. Moreover, in addition to the quantitative alteration in response, there was a change in the inter-relation between response to amphetamine and D3 agonist. A highly significant inverse relation between locomotor inhibitory response to PD 128907 and the locomotor-stimulant response to amphetamine was observed prior to amphetamine treatment. In contrast, 10 days following repetitive amphetamine treatment, the relation between response to PD 128907 and amphetamine was not detected. The observed behavioral alteration could not be accounted for by changes in D3 receptor binding in ventral striatum. These findings suggest a persistent release of D3 receptor-mediated inhibitory influence contributes to the expression of behavioral sensitization to amphetamine.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12700693     DOI: 10.1038/sj.npp.1300182

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  13 in total

1.  Relative expression of D3 dopamine receptor and alternative splice variant D3nf mRNA in high and low responders to novelty.

Authors:  Laurel M Pritchard; Aaron D Logue; Benjamin C Taylor; Rebecca Ahlbrand; Jeffrey A Welge; Yang Tang; Frank R Sharp; Neil M Richtand
Journal:  Brain Res Bull       Date:  2006-07-13       Impact factor: 4.077

2.  Dopaminergic regulation of dopamine D3 and D3nf receptor mRNA expression.

Authors:  Neil M Richtand; Yanhong Liu; Rebecca Ahlbrand; Juliana R Sullivan; Amy Hauck Newman; Robert K McNamara
Journal:  Synapse       Date:  2010-08       Impact factor: 2.562

3.  Distinct roles of dopamine D3 receptors in modulating methamphetamine-induced behavioral sensitization and ultrastructural plasticity in the shell of the nucleus accumbens.

Authors:  Jie Zhu; Yanjiong Chen; Na Zhao; Guofen Cao; Yonghui Dang; Wei Han; Ming Xu; Teng Chen
Journal:  J Neurosci Res       Date:  2012-04       Impact factor: 4.164

4.  Risperidone pretreatment prevents elevated locomotor activity following neonatal hippocampal lesions.

Authors:  Neil M Richtand; Benjamin Taylor; Jeffrey A Welge; Rebecca Ahlbrand; Michelle M Ostrander; Jeffrey Burr; Scott Hayes; Lique M Coolen; Laurel M Pritchard; Aaron Logue; James P Herman; Robert K McNamara
Journal:  Neuropsychopharmacology       Date:  2006-01       Impact factor: 7.853

5.  A functional role for the dopamine D3 receptor in the induction and expression of behavioural sensitization to ethanol in mice.

Authors:  Sarah Jane Harrison; José N Nobrega
Journal:  Psychopharmacology (Berl)       Date:  2009-08-07       Impact factor: 4.530

Review 6.  Behavioral sensitization, alternative splicing, and d3 dopamine receptor-mediated inhibitory function.

Authors:  Neil M Richtand
Journal:  Neuropsychopharmacology       Date:  2006-07-19       Impact factor: 7.853

7.  Divergent effect of the selective D3 receptor agonist pd-128,907 on locomotor activity in Roman high- and low-avoidance rats: relationship to NGFI-A gene expression in the Calleja islands.

Authors:  Marc Guitart-Masip; Björn Johansson; Albert Fernández-Teruel; Adolf Tobeña; Lydia Giménez-Llort
Journal:  Psychopharmacology (Berl)       Date:  2007-10-19       Impact factor: 4.530

8.  Differential susceptibility to ethanol and amphetamine sensitization in dopamine D3 receptor-deficient mice.

Authors:  Sarah Jane Harrison; José N Nobrega
Journal:  Psychopharmacology (Berl)       Date:  2008-12-19       Impact factor: 4.530

9.  In vivo evidence of D3 dopamine receptor sensitization in parkinsonian primates and rodents with l-DOPA-induced dyskinesias.

Authors:  Rosario Sánchez-Pernaute; Bruce G Jenkins; Ji-Kyung Choi; Yin-Ching Iris Chen; Ole Isacson
Journal:  Neurobiol Dis       Date:  2007-05-18       Impact factor: 5.996

10.  Altered dopamine D2-like receptor binding in rats with behavioral sensitization to quinpirole: effects of pre-treatment with Ro 41-1049.

Authors:  Kirsten E Culver; Henry Szechtman; Beth Levant
Journal:  Eur J Pharmacol       Date:  2008-07-04       Impact factor: 4.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.